Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.29271/jcpsp.2021.01.S55 http://scihub22266oqcxt.onion/10.29271/jcpsp.2021.01.S55 33650426!ä!33650426       J+Coll+Physicians+Surg+Pak 2021 ; 31 (1): S55-S56 Nephropedia Template TP {{tp|p=33650426|t=2021. A Single-centre Study of COVID-19 Antibody |pdf=|usr=}}{{33650426}} gab.com Text A Single-centre Study of COVID-19 Antibody JO: J Coll Physicians Surg Pak http://www.kidney.de/pget.php?&tw=1&pmid=33650426 #FOAvip ABSTARCT Four hundred and fifty-three SARS CoV-2 antibodies tests were conducted using Roche Elecsys(R) Anti SARS CoV-2 kits (detecting total antibodies) between June 13 to July 8, 2020 (25 days) on Cobas(R) e411 automatic analyser, based on electrochemiluminescence immunoassay (ECLIA) principle. Samples were collected from walk-in patients at our facility. Among them, 2 (0.4%) were found equivocal, 289 (63.8%) were found reactive, while 162 (35.8%) were found non-reactive. Moreover, reactive (symptomatic) cases were 262 (57.8%), reactive (asymptomatic) were 27 (6.0%), non-reactive (symptomatic) were 34 (7.5%), while non-reactive (asymptomatic) were 128 (28.3%). Most common symptom was fever, found in 262 (87.9%) individuals, followed by dry cough 146 (49.0%). Most number of reactive cases, i.e. 110 (42.6%) were those who got themselves tested between 15-21 days after onset of first symptom. Key Words: COVID-19, Coronavirus, Antibodies testing. Twit Text FOAVip A Single-centre Study of COVID-19 Antibody ????J Coll Physicians Surg Pak http://www.kidney.de/pget.php?&tw=1&pmid=33650426 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33650426 #FOAvip English Wikipedia <ref>{{Cite pmid|33650426}}</ref> A Single-centre Study of COVID-19 Antibody #MMPMID33650426 Ghazanfer S; Mahmood HO J Coll Physicians Surg Pak 2021[Jan]; 31 (1): S55-S56 PMID33650426show ga ABSTARCT Four hundred and fifty-three SARS CoV-2 antibodies tests were conducted using Roche Elecsys(R) Anti SARS CoV-2 kits (detecting total antibodies) between June 13 to July 8, 2020 (25 days) on Cobas(R) e411 automatic analyser, based on electrochemiluminescence immunoassay (ECLIA) principle. Samples were collected from walk-in patients at our facility. Among them, 2 (0.4%) were found equivocal, 289 (63.8%) were found reactive, while 162 (35.8%) were found non-reactive. Moreover, reactive (symptomatic) cases were 262 (57.8%), reactive (asymptomatic) were 27 (6.0%), non-reactive (symptomatic) were 34 (7.5%), while non-reactive (asymptomatic) were 128 (28.3%). Most common symptom was fever, found in 262 (87.9%) individuals, followed by dry cough 146 (49.0%). Most number of reactive cases, i.e. 110 (42.6%) were those who got themselves tested between 15-21 days after onset of first symptom. Key Words: COVID-19, Coronavirus, Antibodies testing. |*Pandemics[MESH] |Antibodies, Viral/*analysis[MESH] |COVID-19/epidemiology/*virology[MESH] |Humans[MESH] |Pakistan/epidemiology[MESH]A Single-centre Study of COVID-19 Antibody (epmc).pdf DeepDyve Pubget Overpricing